Correlation Between Arvinas and Ventyx Biosciences
Can any of the company-specific risk be diversified away by investing in both Arvinas and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arvinas and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arvinas and Ventyx Biosciences, you can compare the effects of market volatilities on Arvinas and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arvinas with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arvinas and Ventyx Biosciences.
Diversification Opportunities for Arvinas and Ventyx Biosciences
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Arvinas and Ventyx is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Arvinas and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Arvinas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arvinas are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Arvinas i.e., Arvinas and Ventyx Biosciences go up and down completely randomly.
Pair Corralation between Arvinas and Ventyx Biosciences
Given the investment horizon of 90 days Arvinas is expected to under-perform the Ventyx Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Arvinas is 1.55 times less risky than Ventyx Biosciences. The stock trades about -0.06 of its potential returns per unit of risk. The Ventyx Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 206.00 in Ventyx Biosciences on November 4, 2024 and sell it today you would lose (5.00) from holding Ventyx Biosciences or give up 2.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arvinas vs. Ventyx Biosciences
Performance |
| Timeline |
| Arvinas |
| Ventyx Biosciences |
Arvinas and Ventyx Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arvinas and Ventyx Biosciences
The main advantage of trading using opposite Arvinas and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arvinas position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.| Arvinas vs. C4 Therapeutics | Arvinas vs. Monte Rosa Therapeutics | Arvinas vs. Nurix Therapeutics | Arvinas vs. Foghorn Therapeutics |
| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |